Close

Analyst Ratings for Codiak Biosciences Inc. (CDAK)

CDAK Rating Summary

  |   Expand Research on CDAK
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/1/2022 Goldman Sachs
» Updated 11/7/2022
Andrea Tan Downgrade Neutral
(Buy)
1.20
(2.00)
2.24
(0.06)
-97.32% Details
11/9/2020 Wedbush
» Updated 2/22/2022
David Nierengarten New Coverage Outperform
(N/A)
24.00
(34.00)
9.09
(0.06)
-99.34% Details
Like CDAK Ratings? Also take a look at JPM, AXP, IBM, NKE

CDAK Ratings News